How CFDA Transition to NMPA Changed Clinical Trials
How CFDA Transition to NMPA Changed Clinical Trials The Transformation of Clinical Trials in China: From CFDA to NMPA Introduction The transition from the China Food and Drug Administration (CFDA) to the National Medical Products Administration (NMPA) in 2018 marked a pivotal moment in the modernization of China’s clinical trial and regulatory landscape. For decades,…
Read More “How CFDA Transition to NMPA Changed Clinical Trials” »